SCHEMBL7292049

SCHEMBL7292049

O=C(O)C(c1c[nH]c2ccc(O)cc12)c1c[nH]c2ccc(O)cc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 6/20 0.55
▸ HTR2C P28335 6/20 0.55
▸ ALDH1A1 P00352 4/20 0.55
▸ HTR1A P08908 4/20 0.55
▸ HTR2A P28223 4/20 0.55
▸ HTR2B P41595 4/20 0.55
▸ KDM4E B2RXH2 4/20 0.55
▸ LMNA P02545 3/20 0.55
▸ NFKB1 P19838 3/20 0.55
▸ TSHR P16473 3/20 0.55
▸ BLM P54132 3/20 0.55
▸ CYP3A4 P08684 3/20 0.55
▸ MAPT P10636 3/20 0.55
▸ PMP22 Q01453 2/20 0.55
▸ HTR7 P34969 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ ADORA3 P0DMS8 1/20 0.55
▸ ALOX15 P16050 1/20 0.55
▸ SLC6A4 P31645 1/20 0.55
▸ MTOR P42345 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1667862 0.84 NPSR1 (0.59) NPSR1HTR2CALDH1A1HTR1AHTR2A
SCHEMBL2494144 0.84 HTR2C (0.52) NPSR1HTR2CALDH1A1HTR1AHTR2A
SCHEMBL7289880 0.81 NPSR1 (0.59) NPSR1HTR2CALDH1A1HTR1AHTR2A
SCHEMBL28422454 0.80 NPSR1 (0.55) NPSR1HTR2CALDH1A1HTR1AHTR2A
SCHEMBL9536748 0.80 NPSR1 (0.56) NPSR1HTR2CALDH1A1HTR1AHTR2A
SCHEMBL10719515 0.78 NPSR1 (0.47) NPSR1HTR2CALDH1A1HTR1AHTR2A
SCHEMBL7047429 0.77 MEN1 (0.59) HTR2CHTR2AHTR2BKDM4ELMNA
SCHEMBL6516528 0.77 HTR2C (0.55) NPSR1HTR2CALDH1A1HTR1AHTR2A
SCHEMBL29414816 0.77 HTR2C (0.55) NPSR1HTR2CALDH1A1HTR1AHTR2A
SCHEMBL10821180 0.76 NPSR1 (0.51) NPSR1HTR2CALDH1A1HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991645-A1 BIS-INDOLE DERIVATIVES HAVING ANTIMETASTATIC ACTIVITY, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Roche Diagnostics GmbH (DE) 2000-04-12 — — EP claimed
WO-1999000381-A1 BIS-INDOLE DERIVATIVES HAVING ANTIMETASTATIC ACTIVITY, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROCHE DIAGNOSTICS GMBH (DE) 1999-01-07 — — WO claimed
EP-0887348-A1 Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them Boehringer Mannheim Italia S.p.A. (IT) 1998-12-30 — — EP claimed
EP-0991645-A1 BIS-INDOLE DERIVATIVES HAVING ANTIMETASTATIC ACTIVITY, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Roche Diagnostics GmbH (DE) 2000-04-12 — — EP disclosed
WO-1999000381-A1 BIS-INDOLE DERIVATIVES HAVING ANTIMETASTATIC ACTIVITY, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROCHE DIAGNOSTICS GMBH (DE) 1999-01-07 — — WO disclosed
EP-0887348-A1 Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them Boehringer Mannheim Italia S.p.A. (IT) 1998-12-30 — — EP disclosed
Send feedback